RecruitingNot ApplicableNCT06008899

Efficacy of Ultrasound-assisted Caudal Epidural Pulsed Radiofrequency for Anal Pain in Cancer Patients,

Efficacy of Ultrasound-assisted Caudal Epidural Pulsed Radiofrequency for Anal and Perineal Pain in Cancer Patients, a Prospective Randomized Clinical Study


Sponsor

Assiut University

Enrollment

40 participants

Start Date

Aug 25, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

Our primary goal will be to investigate the analgesic efficacy of ultrasound (US)-assisted caudal epidural PRF (pulsed radiofrequency)( stimulation in patients with perineal or anal pain cancer patients using (visual analog scale (VAS) scores from 0 to 10 at the baseline (pretreatment), two, four, and eight weeks; secondary outcomes will be the effects on opioid use and total opioid use in the 24 h, quality of life, patient satisfaction and opioid and intervention related side effects.


Eligibility

Min Age: 18 YearsMax Age: 60 Years

Inclusion Criteria2

  • American Society of Anesthesiology physical status of I or III (ASA), of both sex
  • cancer-related anal or perineal pain

Exclusion Criteria3

  • coagulopathies
  • allergies to the contrast dye
  • patients with moderate or significant cardiac/respiratory disease or hepatic

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREUS assisted caudal epidural pulsed radiofrequency

patients will receive US assisted caudal epidural pulsed radiofrequency and followed up to 8 weeks


Locations(1)

South Egypt Cancer instIitute

Asyut, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06008899


Related Trials